The study found that overexpression of regucalcin inhibited proliferation, cell death, and migration in human pancreatic cancer MIA PaCa-2 (K-ras mutated) cells, which are resistant to drug and radiation therapy [35]. The gene discussed is KRAS; the disease is pancreatic neoplasm.